layoffs rmor/ read todays WSJ

Quote












Novartis CEO: iPad saves time, keeps reps honest

March 29, 2011 — 10:49am ET | By Howard Lovy

The iPad is being promoted by Novartis CEO Joe Jimenez as a technological miracle drug that will allow sales reps to pitch to tens of thousands customers each year, save hundreds of hours, keep them more honest and even cost them their jobs--presumably a good thing for the company but not for the rep. This is according to a report in the Pharmalot blog, quoting from a note Jimenez reportedly wrote to employees.

Pharmalot quotes Jimenez as saying that the iPad "will make it possible for sales reps to save 250 hours over the course of the year and allow 'the entire field force to make an incredible 35,000 additional customer visits each year.'" As an illustration, Pharmalot's Ed Silverman points out that Novartis did axe 1,400 sales reps recently, then asks: "A few more iPads and perhaps a few more hundred reps will go?" Additionally, Jimenez observes that paper records leave room for some fudging. Electronic materials, presumably, are harder to alter.

It appears Joe believes reps are only working part time and that if he can bring in big brother to make them work more, then he can cut more jobs because of the increased productivity. Remember, I Pads have GPS location devices.
 






Anonymous said:
Novartis CEO: iPad saves time, keeps reps honest

March 29, 2011 — 10:49am ET | By Howard Lovy

The iPad is being promoted by Novartis CEO Joe Jimenez as a technological miracle drug that will allow sales reps to pitch to tens of thousands customers each year, save hundreds of hours, keep them more honest and even cost them their jobs--presumably a good thing for the company but not for the rep. This is according to a report in the Pharmalot blog, quoting from a note Jimenez reportedly wrote to employees.

Pharmalot quotes Jimenez as saying that the iPad "will make it possible for sales reps to save 250 hours over the course of the year and allow 'the entire field force to make an incredible 35,000 additional customer visits each year.'" As an illustration, Pharmalot's Ed Silverman points out that Novartis did axe 1,400 sales reps recently, then asks: "A few more iPads and perhaps a few more hundred reps will go?" Additionally, Jimenez observes that paper records leave room for some fudging. Electronic materials, presumably, are harder to alter.

It appears Joe believes reps are only working part time and that if he can bring in big brother to make them work more, then he can cut more jobs because of the increased productivity. Remember, I Pads have GPS location devices.
Click to expand...

Can't you disable the GPS, like you can on a cell phone?
 






Anonymous said:
http://pharmacyblogbuy.com/novartis-chief-continues-cost-cutting-drive/
Click to expand...


Novartis chief continues cost-cutting drive

Novartis ($NVS) chief Joe Jimenez (photo) started slashing expenses at the drugmaker even before he took over the CEO’s job. That cost-cutting has continued apace, with jobs and facilities facing the axe since his tenure began. And it’s likely to continue at a similarly brisk pace going forward, the Wall Street Journal reports, as pricing pressures and generic competition continues.
Let’s review the cuts so far: As pharma chief, Jimenez changed procurement policies to shave 10 percent to 15 percent off purchasing costs. As CEO, he cut 1,500 jobs and launched a manufacturing-efficiency drive–one that recently claimed a U.K. plant, and 500 jobs along with it. It’s all part of Jimenez’s bid to make Chairman Daniel Vasella’s (photo) ”focused diversification” strategy work.
“Historically, the pharmaceuticals industry hasn’t focused as much on cost reduction,” Jimenez says. That’s changed over the last couple of years, of course, as the patent cliff steadily approached and Big Pharma started shedding jobs by the thousands. But Jimenez says his cost-cutting focus is different from the rest: He’s not cutting just to boost margins, but also to free up money to invest in R&D. He figures that more and better R&D will lead to higher sales.
 
























Well that's better than the last excuse for the latest layoff. He said at that time it was to get back to "double-digit" growth. I guess 9% wasn't good enough. There definitely needs to be some R&D so there won't be another CV drug launch anytime soon. Enough already. I would suggest everyone get their resumes updated cause it won't be long now till phase II. if they needed to cut 1500 to get to double digit growth how many more for R&D dollars? Can't imagine what the work load will be on all you poor slobs that remain! At least you'll have a job. Doesn't that make you feel secure. I'm sure though that layoffs are still a rumor...maybe!
 


















That is just genius. All reps can just self manage themselves. No need for any FLMs, Directors, or what the hell, no HR, no marketing, no nothing- Just real smart reps like you that need no support or direction because you are so brilliant. If you want no boss, then start your own company....until then shut the fuck up and do what your told as you are already overpaid.
 
























Anonymous said:
Joe needs to lay off FLM's and MD's. What a complete waste of money. At least reps do promote products and the FLM & MD has to find a way to justify their jobs.
Click to expand...

Or a real easy cut would be the REE BRM's . All mine does is piggyback on everyone's lunches & take credit for things like he made a difference.
 


















Top Bottom
Back
Quote